UIMA:XETRA:XETRA-UBS ETF SICAV - MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 82.54

Change

+0.02 (+0.02)%

Market Cap

USD 0.24B

Volume

709.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.80 (-1.54%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.33 (-1.97%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.46%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.13 (-0.44%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.23 (-0.93%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.23 (-0.49%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-0.86 (-0.60%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.28 (-0.54%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.39 (+0.37%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+2.70 (+0.45%)

USD 80.38B

ETFs Containing UIMA:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.71% 37% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.71% 35% F 40% F
Trailing 12 Months  
Capital Gain 10.35% 44% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.35% 41% F 45% F
Trailing 5 Years  
Capital Gain 23.43% 50% F 55% F
Dividend Return 8.22% 48% F 36% F
Total Return 31.65% 55% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 8.88% 64% D 63% D
Dividend Return 9.95% 67% D+ 65% D
Total Return 1.07% 69% C- 48% F
Risk Return Profile  
Volatility (Standard Deviation) 12.00% 52% F 61% D-
Risk Adjusted Return 82.93% 79% B- 82% B
Market Capitalization 0.24B 49% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.